pv. Type III Effectors Localized at Multiple Cellular Compartments Activate or Suppress Innate Immune Responses in .

Front Plant Sci

Bioprotection Research Centre, Institute of Agriculture and Environment, Massey University, Palmerston North, New Zealand.

Published: December 2017

Bacterial phytopathogen type III secreted (T3S) effectors have been strongly implicated in altering the interaction of pathogens with host plants. Therefore, it is useful to characterize the whole effector repertoire of a pathogen to understand the interplay of effectors in plants. pv. is a causal agent of kiwifruit canker disease. In this study, we generated an -mediated transient expression library of YFP-tagged T3S effectors from two strains of , -NZ V13 and -NZ LV5, in order to gain insight into their mode of action in and . Determining the subcellular localization of effectors gives an indication of the possible host targets of effectors. A confocal microscopy assay detecting YFP-tagged effectors revealed that the nucleus, cytoplasm and cell periphery are major targets of effectors. -mediated transient expression of multiple effectors induced HR-like cell death (HCD) in spp., suggesting that multiple effectors may be recognized by spp.. Virus-induced gene silencing (VIGS) of several known plant immune regulators, , , or specified the requirement of SGT1 in HCD induced by several effectors in . In addition, the suppression activity of effectors on HCD-inducing proteins and PTI was assessed. effectors showed differential suppression activities on each HCD inducer or PTI. Taken together, our effector repertoire analysis highlights the great diversity of T3S effector functions .

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742410PMC
http://dx.doi.org/10.3389/fpls.2017.02157DOI Listing

Publication Analysis

Top Keywords

effectors
13
type iii
8
t3s effectors
8
effector repertoire
8
-mediated transient
8
transient expression
8
targets effectors
8
multiple effectors
8
iii effectors
4
effectors localized
4

Similar Publications

Major Depressive Disorder (MDD) is a widespread psychiatric condition impacting social and occupational functioning, making it a leading cause of disability. The diagnosis of MDD remains clinical, based on the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria, as biomarkers have not yet been validated for diagnostic purposes or as predictors of treatment response. Traditional treatment strategies often follow a one-size-fits-all approach obtaining suboptimal outcomes for many patients who fail to experience response or recovery.

View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) is a highly malignant and aggressive gastrointestinal tumor. Due to its weak immunogenicity and limited immune, cell infiltration lead to ineffective clinical outcomes. Therefore, to improve the current prophylaxis and treatment scheme, offering a favorable strategy efficient against CRC is urgently needed.

View Article and Find Full Text PDF

CD7-targeted chimeric antigen receptor-T (CAR-T) cell therapy has shown great promise in the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL). In this study, we reported a case of a 34-year-old male patient with T-ALL who finally developed multi-line drug resistance and refractoriness after multiple lines of high-intensity chemotherapy. After physician evaluation, this patient received allogeneic hematopoietic stem cell transplantation (allo-HSCT).

View Article and Find Full Text PDF

Human natural killer (NK) cells can be sub-divided into two functional subsets but the clinical significance of these CD56 and CD56 NK cells in anti-tumour immunity remains largely unexplored. We determined the relative abundances of gene signatures for CD56 and CD56 NK cells along with 3 stromal and 18 other immune cell types in the patient tumour transcriptomes from the cancer genome atlas bladder cancer dataset (TCGA-BLCA). Using this computational approach, CD56 NK cells were predicted to be the more abundant tumour-infiltrating NK subset which was also associated with improved patient prognosis.

View Article and Find Full Text PDF

The cell autonomous and non-autonomous roles of itaconate in immune response.

Cell Insight

February 2025

Key Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

Itaconate which is discovered as a mammalian metabolite possessing antimicrobial and immunoregulatory activity has attracted much attention in the field of immunometabolism. Itaconate is synthesized by myeloid cells under conditions of pathogen infection and sterile inflammation. In addition to regulating immune response of myeloid cells, itaconate secreted from myeloid cells can also be taken up by non-myeloid cells to exert immunoregulatory effects in a cell non-autonomous manner.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!